RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
06 mars 2025 06h00 HE
|
RetinalGeniX Technologies, Inc.
RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
20 févr. 2025 06h30 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING
High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes
Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts
19 févr. 2025 09h00 HE
|
The Eye Health Summit
The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event.
[Latest] Global Dry Eye Syndrome Treatment Market Size/Share Worth USD 12,281.4 Million by 2033 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
11 déc. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative...
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
23 oct. 2024 07h00 HE
|
OKYO Pharma LTD
OK-101 is the first drug candidate to enroll patients specifically diagnosed with Neuropathic Corneal Pain (NCP) in a clinical trialThe Phase 2 trial is designed as a randomized, placebo-controlled,...
[Latest] Global Cosmetic Pigments Market Size/Share Worth USD 4.9 Billion by 2033 at a 6.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
24 juin 2024 09h40 HE
|
Custom Market Insights
Austin, TX, USA, June 24, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cosmetic Pigments Market Size, Trends and Insights By Type (Surface Treated...
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
22 févr. 2024 06h05 HE
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Granted A New Patent for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
01 févr. 2024 01h03 HE
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
01 déc. 2023 12h32 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
30 nov. 2023 08h05 HE
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.